Christopher C. Williams to Estrogen Receptor alpha
This is a "connection" page, showing publications Christopher C. Williams has written about Estrogen Receptor alpha.
Connection Strength
1.237
-
Williams MD, Nguyen T, Carriere PP, Tilghman SL, Williams C. Protein Kinase CK2 Expression Predicts Relapse Survival in ERa Dependent Breast Cancer, and Modulates ERa Expression in Vitro. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010036.
Score: 0.527
-
Williams CC, Basu A, El-Gharbawy A, Carrier LM, Smith CL, Rowan BG. Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2. BMC Biochem. 2009 Dec 31; 10:36.
Score: 0.348
-
Huderson BP, Duplessis TT, Williams CC, Seger HC, Marsden CG, Pouey KJ, Hill SM, Rowan BG. Stable inhibition of specific estrogen receptor a (ERa) phosphorylation confers increased growth, migration/invasion, and disruption of estradiol signaling in MCF-7 breast cancer cells. Endocrinology. 2012 Sep; 153(9):4144-59.
Score: 0.103
-
Duplessis TT, Williams CC, Hill SM, Rowan BG. Phosphorylation of Estrogen Receptor a at serine 118 directs recruitment of promoter complexes and gene-specific transcription. Endocrinology. 2011 Jun; 152(6):2517-26.
Score: 0.095
-
Murphy LC, Skliris GP, Rowan BG, Al-Dhaheri M, Williams C, Penner C, Troup S, Begic S, Parisien M, Watson PH. The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo. J Steroid Biochem Mol Biol. 2009 Mar; 114(1-2):90-5.
Score: 0.082
-
Skliris GP, Rowan BG, Al-Dhaheri M, Williams C, Troup S, Begic S, Parisien M, Watson PH, Murphy LC. Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas. Breast Cancer Res Treat. 2009 Dec; 118(3):443-53.
Score: 0.081